INTRODUCTION
T his study was undertaken to identify barriers to care and opportunities to improve care for patients with diabetes seen in safety net practices. We sought to illuminate the perspectives of the patients and their clinicians in practices where the poorest people receive their health care.
The epidemic of type 2 diabetes in the United States [1] [2] [3] is nowhere more apparent than in the safety net practices that serve on the front lines 4 of a health care system, with limited access to care for the poor. 5, 6 Safety net practices focus on improving patient outcomes by reducing disparities and barriers to care. The vast majority of people they serve are in racial and low-socioenomic-status groups with well-documented disparities in diabetes care and outcomes. 7, 8 Safety net practices often work in isolation on the front lines of a dysfunctional health care "system." 9 Local networking among safety net practices could help to overcome this isolation and generate relevant new knowledge. Therefore, we developed a network of safety net providers in Cleveland, Ohio. At the time of this study, Cleveland was the poorest city in the nation, Objective: To identify barriers and opportunities for quality diabetes care in safety net practices.
Methods: In 3 federally qualified health centers and 1 free clinic, 19 primary care clinicians profiled patient and visit characteristics and quality of care measures for 181 consecutive visits by adult type 2 diabetic patients. Open-ended questions assessed patient and clinician perception of barriers to diabetes care and patient report of enabling factors. A multidisciplinary team identified themes from open-ended responses. Logistic regression analyses assessed the association of the identified barriers/enablers with 2 measures of quality care: glycosylated hemoglobin and prophylactic aspirin use.
Results: Ranked barriers noted by patients included adherence (40%), financial/insurance (23%), and psychosocial (13%) factors. Clinicians ranked systemic factors, including financial/ insurance (32%) and cultural/psychosocial (29%) factors, as important to adherence (29%) in determining quality diabetes care. Patients reported dietary and medical adherence (37%) and family/health care worker support (17%) as helpful factors. Among 175 patients with available data, glycosylated hemoglobin levels were associated with patient report of financial/ insurance factors both as a barrier when visits and medications were unaffordable and as an opportunity when free or lowcost medications and services were provided. Patients' adherence with aspirin prophylaxis was strongly associated with African American race, prior prescription of aspirin and distribution of aspirin at the practice site (p < .001).
Conclusions:
Patients were less likely than clinicians to identify systemic and contextual factors contributing to poor diabetes care. From the front line's perspective, enabling be locally useful and nationally relevant to other urban safety net practices. This Safety Net Providers' Strategic Alliance (SNPSA) first met in 2004 with the goals of leveraging local learning to improve the quality of care, sharing resources, and fostering advocacy for policy change to close holes in the safety net. Based on a series of meetings among practice clinicians and administrators, we identified diabetes quality of care as a vital issue affecting the lives of a large number of our patients. As our meetings continued, the group developed into a practice-based research network. Practicebased research networks are groups of practices which are primarily devoted to patient care that band together to conduct research from the perspective of the clinicians. 11 This paper reports the first study of this new practice-based research network of safety net providers.
METHODS
This was a cross-sectional study of established patients with type 2 diabetes from urban primary care safety net practices within the SNPSA practice-based research network. The SNPSA is a consortium of urban safety net practices in greater Cleveland. Medical directors and clinician-leaders of SNPSA-member practices collaborated with academic investigators to design the study and invited other primary care clinicians within SNPSA practices to voluntarily participate in the study. Study procedures involved recording deidentified clinical information from patients' medical charts. Because of this, waivers of informed consent and HIPAA were granted by the Case Western Reserve University institutional review board at University Hospitals of Cleveland.
We used a modification of the weekly return card method 12 that has been shown to result in valid and reliable data about the clinical encounter. 13 The weekly return card method involves clinicians in systematically recording observations about consecutive patients that meet enrollment criteria. Each participating clinician was asked to record data elements about the content of office visits by 10 consecutive patients aged 18 and older with a previous diagnosis of type 2 diabetes, beginning on a randomly selected practice day. Clinicians were instructed to employ their usual approach to diabetes care during the data collection period and to specifically ask patients about barriers and enablers for their diabetes care, and making and recording their own assessment of the barriers to quality diabetes care for each patient. Completed data collection cards were mailed to the study coordinating center.
We collected the following data elements: patient demographics (age, race, ethnicity), homelessness status, insurance type, prescription drug coverage, body mass index, most recent glycosylated hemoglobin level and length of time since the last test, whether aspirin was distributed to the patient on-site, and current adherence with aspirin prescription. In addition, clinicians elicited and recorded patients' reported barriers to managing diabetes and factors that enabled patients to manage their diabetes. Clinicians also recorded their own impression of patients' barriers to managing diabetes.
We entered by hand and verified the data from the cards. A multidisciplinary team, including a physician, 2 social scientists, and a health care administrator coded responses to the open-ended questions. They identified themes within each question (about barriers or enablers to quality diabetes care), grouped each response within these categories, and counted the number of responses in each category. A few items were classified into multiple categories.
We calculated descriptive statistics and then used c 2 , Fischer's exact test, or t tests to assess the univariable association of descriptive variables with 2 outcomes: glycosylated hemoglobin and prophylactic aspirin use. Next we entered variables that were associated at p < .1 into logistic regression analyses to identify the most parsimonious set of factors associated with these outcomes. We designated variables at p < .05 as significant and, in this exploratory study, interpreted trends in variables associated at p < .1. 
RESULTS
Four urban practices and 19 clinicians collected data for the study. The practices included a free clinic and 3 federally qualified community health centers, each serving a slightly different population. The Free Clinic and Care Alliance serve an ethnically diverse uninsured pop- previously been prescribed aspirin prophylaxis, and 70% reported that they were taking aspirin currently. Table 1 shows the characteristics of the participating diabetic patients. Tables 2 and 3 show both the results of both univariable and logistic regression analyses of factors associated with an A 1c of less than or equal to 7 and prescription of aspirin, respectively. These tables include the domains of responses to the open-ended questions about patient-and clinician-perceived barriers to managing diabetes, patient-reported enablers, and the percent of patients for whom a response in each domain was reported.
For A 1c , (Table 2 ) univariable associations of insurance type and a lack of barriers disappeared in analyses controlling for age, race, and the univariate significant variables. However, patient report of having financial and insurance barriers or factors which helped with financial and insurance issues remained significant in the multivariable analysis. Clinician report of knowledge/education as a barrier was borderline significant.
In analyses of factors associated with patients taking aspirin (Table 3) , the univariable associations of age, race, distribution of aspirin on site, and clinician report of knowledge/education as a barrier disappeared in multivariable analyses, whereas previous prescription of low-dose aspirin remained significant. Table 4 shows the concordance of clinician and patient report of barriers to diabetic control. Notably, patients were most likely to report their adherence as the major barrier, whereas clinicians most commonly reported financial barriers. A predictive model of A 1c level achieved a sensitivity of 87% and a specificity of 41% with a positive predictive value of 74%.
DISCUSSION
This study is important because it identifies barriers and opportunities for improved diabetes care among the vulnerable patients served by a research network of safety net practices. Patients report their own adherence with health behavior change and medical treatment as the main barrier to diabetes care, whereas clinicians rank systemic factors as similarly important to adherence and health behaviors.
The patient-and clinician-reported barriers give a sense of the complex and difficult lives experienced by people living in poverty. These data show that complex life circumstances and events lie behind the terms noncompliance and nonadherence. The differences in the relative frequency of clinician and patient reporting of adherence as a barrier are interesting. Although physicians in the safety net practices acknowledge larger systematic factors, patients themselves attributed noncompliance/nonadherence to their own actions. Patients' inability to see the impact of larger factors on their own personal troubles is consistent with other literature.
14 This perspective may be reinforced when clinicians focus exclusively on individual-level solutions. Self-blame may predispose patients to learned helplessness leading to poor self-management behaviors. It may be helpful for clinicians to guide patients' identification of both systemic issues and factors that are fully under patients' control. The totality of the findings argue for a greater emphasis on systemic solutions that are less focused on blaming people and more focused on supporting the needed behavior change among clinicians and patients.
The larger lists of barriers compared to enabling factors highlight the greater visibility of problems than potential solutions. Improved case management support in safety net practices would allow the identification and utilization of enabling factors to improve diabetic care.
The outcomes of optimal glycosylated hemoglobin level and patient report of adherence to aspirin prophylaxis are associated with systemic factors: patient report of lack of financial and insurance issues for glycosylated hemoglobin, and distribution of aspirin on site for aspirin use. We observed nonsignificant trends toward patient knowledge and education as being a factor for both outcomes.
Some of the null findings are provocative. The findings that homelessness, race and insurance type did not predict either A 1c level or use of aspirin, that the average glycosylated hemoglobin level was similar to the national average, [15] [16] [17] [18] and that aspirin adherence was better than previously reported levels 19, 20 may indicate the effectiveness of safety net practices in partially overcoming barriers to care that are a major source of health disparities. 21 The data from this study support additional safety net practice innovations, such as providing aspi- rin on site and tailoring care toward the unique needs of the homeless, non-English speakers, and those with challenging life situations.
The data on the association of insurance type with glycosylated hemoglobin hint at the complexity of the task of providing systems solutions. The data imply a Appendix. Data Collection Instrument trend toward patients on Medicare having better control. Indeed, these patients have a government insurance that pays for diabetes management supplies and teaching to a greater extent than commercial insurance and, of course, no insurance. Medicaid insurance provides some of the same coverage, but patient's ability to be enrolled is more likely to be sporadic and short-term and may be associated with significant mental illness. [22] [23] [24] In addition, the disability or life-stage criteria for Medicaid enrollment select for patients with many competing demands for diabetes control. 25, 26 How to provide systems support for diabetes control amidst these competing personal and systemic demands is an important topic for future inquiry.
The findings of this study should be interpreted in the context of its strengths and limitations. The data were reported by clinicians who often knew the patients well. This may increase the validity of some of the findings but could engender biases, particularly in reporting of patient-perceived barriers and enablers. In particular, it is possible that patients may have been reluctant to identify factors that criticized their clinician or practice, since the data were being collected by their clinician. The sample of patients, clinicians and practices is small. Some of the observed trends may have been significant in larger samples, and different safety net practices in different areas of the country may have made different adaptations to their patient populations that would have resulted in different results. Different data collection methods also may have identified other barriers and enablers of diabetes control.
However, the point of the study is to examine diabetes care from the perspectives of the front lines of caring for the disadvantaged. The findings reported here provide hope that an expanded and enhanced safety net is a solution to improving the quality of diabetes care and reducing disparities. These findings point toward a need for a greater focus on systems approaches, in combination with continued personalized focus on the individual, family, and local communities. The Health Disparities Collaborative (HDC) of the Bureau of Primary Health Care, a national best practice model for treatment of chronic illnesses, 27 provides tools for chronic disease management to those clinicians practicing at federally qualified health centers. The HDC parallels the disease-specific collaboratives developed by the Institute for Healthcare Improvement. 28 Expansion of the HDC to free clinics and private practices located in impoverished areas would extend the reach of these valuable tools to greater numbers of patients.
This study also shows the potential of a practicebased research network of safety net practices to generate useful data for understanding and improving patient care. We also found that the safety net meetings overcame isolation of providers and enhanced their ability to do the collective work of providing care to their communities. Meeting in this group format has motivated us to ramp up our care and collaborate with our colleagues, who in that past may have seemed to be competitors. We have increased our resolve to tighten the safety net by continuing our research on health care barriers, implementing solutions in our practices, and creating a strong advocacy program to encourage systemic change. Future research should develop the safety net practice infrastructure and pursue the findings of this study in an expanded network, eventually leading to interventions that are grounded in the experience of those at the front lines of caring for the needy.
